Impact of diuretics use in long-term management of congestive heart failure patients to prevent re-hospitalization using the Diagnosis Procedure Combination Database
Not Applicable
- Conditions
- Heart failure
- Registration Number
- JPRN-UMIN000046107
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department
- Brief Summary
In this study, compared to loop diuretics, additional tolvaptan treatment was not shown to be effective for the time to readmission due to heart failure. Re-hospitalization for heart failure has been shown to be associated with age, Na, creatinine, and prescriptions of ACE inhibitors or ARBs and thiazides. On the other hand, additional treatment with tolvaptan was shown to be significantly longer in terms of time to in-hospital death.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 11257
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients younger than 20 years at the time of the second hospitalization for the disease of interest
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of readmissions due to HF and time to readmission during the second post-discharge follow-up period (after 1 year)
- Secondary Outcome Measures
Name Time Method In-hospital death